首页 > 最新文献

Problemy endokrinologii最新文献

英文 中文
[Metastatic pituitary lesion]. [转移性垂体病变]。
Pub Date : 2024-11-05 DOI: 10.14341/probl13395
A M Lapshina, E A Bazarova, E G Przhialkovskaya, P M Khandaeva, V N Azizyan, A Yu Grigoriev, O V Ivashchenko, N V Tarbaeva, Zh E Belaya

Metastatic lesion of pituitary is a rare condition and is diagnosed in 1.8-4% of cases. Monitoring and treatment of such patients is a complex task and requires increased attention from a multidisciplinary team of specialists. The authors represent three patients with metastatic pituitary lesion who underwent neurosurgical treatment at the National Research Center of the National Research Institute of Endocrinology with subsequent pathomorphological confirmation of the diagnosis. The primary tumors were breast cancer, lung carcinoid, and clear cell kidney cancer. Two patients had distant metastases other than the pituitary gland. The clinical manifestation consisted in the appearance of symptoms of panhypopituitarism, chiasmal syndrome and mass effect in all cases. The follow-up period after surgical treatment was 0.25-2.5 years. Progression of the underlying disease was noted in two patients. One of them carried out stereotactic radiosurgical treatment and stereotactic oriented irradiation. One patient has a stable condition.

垂体转移性病变是一种罕见病,确诊率为 1.8%-4%。对这类患者的监测和治疗是一项复杂的任务,需要多学科专家团队的更多关注。作者介绍了三名患有转移性垂体病变的患者,他们在国家内分泌研究所的国家研究中心接受了神经外科治疗,随后进行了病理形态学确诊。原发肿瘤为乳腺癌、肺类癌和透明细胞肾癌。两名患者有垂体以外的远处转移。所有病例的临床表现均为泛垂体功能障碍、脉络膜综合征和肿块效应。手术治疗后的随访期为 0.25-2.5 年。有两名患者的基础疾病有所进展。其中一名患者接受了立体定向放射外科治疗和立体定向照射。一名患者病情稳定。
{"title":"[Metastatic pituitary lesion].","authors":"A M Lapshina, E A Bazarova, E G Przhialkovskaya, P M Khandaeva, V N Azizyan, A Yu Grigoriev, O V Ivashchenko, N V Tarbaeva, Zh E Belaya","doi":"10.14341/probl13395","DOIUrl":"https://doi.org/10.14341/probl13395","url":null,"abstract":"<p><p>Metastatic lesion of pituitary is a rare condition and is diagnosed in 1.8-4% of cases. Monitoring and treatment of such patients is a complex task and requires increased attention from a multidisciplinary team of specialists. The authors represent three patients with metastatic pituitary lesion who underwent neurosurgical treatment at the National Research Center of the National Research Institute of Endocrinology with subsequent pathomorphological confirmation of the diagnosis. The primary tumors were breast cancer, lung carcinoid, and clear cell kidney cancer. Two patients had distant metastases other than the pituitary gland. The clinical manifestation consisted in the appearance of symptoms of panhypopituitarism, chiasmal syndrome and mass effect in all cases. The follow-up period after surgical treatment was 0.25-2.5 years. Progression of the underlying disease was noted in two patients. One of them carried out stereotactic radiosurgical treatment and stereotactic oriented irradiation. One patient has a stable condition.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"46-53"},"PeriodicalIF":0.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role of leptin in endometrium disorders: literature review]. [瘦素在子宫内膜疾病中的作用:文献综述]。
Pub Date : 2024-11-05 DOI: 10.14341/probl13397
K D Ievleva, I N Danusevich, L V Suturina

Leptin is not only the main regulator of energy balance, but also it affects the reproductive and immune systems. Leptin and its receptors are expressed in the endometrium and are actively involved in the embryo implantation. According to numerous studies, expression and level changes of leptin are associated with the inflammatory and autoimmune diseases, including endometriosis and chronic endometritis. Hyperplastic and inflammatory diseases of the uterus are accompanied by a violation of the receptivity of the endometrium due to the dysregulation of many factors involved in proliferation, vascularization and decidualization of cells. Activity of most of these factors is due to the leptin action, however, there are no studies of the direct effect of leptin in the pathogenesis of disorders of the endometrium in hyperplastic and inflammatory diseases.Thus, the purpose of this literature review was to describe the putative molecular mechanisms of the effect of leptin on the development of endometrial pathology.Literature search was carried out from 03/20/2023 to 05/11/2023 using scientific literature databases: NCBI PubMed, Google Scholar (foreign sources), Cyberleninka, Elibrary (domestic sources): references for the period 1995-2023 were analyzed. The following keywords were used for the search: leptin, endometrial dysfunction, endometrial receptivity, inflammation, pelvic inflammatory disease.

瘦素不仅是能量平衡的主要调节器,还会影响生殖和免疫系统。瘦素及其受体在子宫内膜中表达,并积极参与胚胎着床。大量研究表明,瘦素的表达和水平变化与炎症和自身免疫性疾病有关,包括子宫内膜异位症和慢性子宫内膜炎。子宫增生性疾病和炎症性疾病伴随着子宫内膜接受能力的下降,这是由于许多参与细胞增殖、血管化和蜕膜化的因子失调所致。然而,目前还没有关于瘦素在子宫内膜增生性和炎症性疾病发病机制中的直接作用的研究。因此,本文献综述的目的是描述瘦素对子宫内膜病理发展的影响的假定分子机制:NCBI PubMed、Google Scholar(国外来源)、Cyberleninka、Elibrary(国内来源):分析了 1995-2023 年期间的参考文献。搜索时使用了以下关键词:瘦素、子宫内膜功能障碍、子宫内膜接受性、炎症、盆腔炎。
{"title":"[The role of leptin in endometrium disorders: literature review].","authors":"K D Ievleva, I N Danusevich, L V Suturina","doi":"10.14341/probl13397","DOIUrl":"https://doi.org/10.14341/probl13397","url":null,"abstract":"<p><p>Leptin is not only the main regulator of energy balance, but also it affects the reproductive and immune systems. Leptin and its receptors are expressed in the endometrium and are actively involved in the embryo implantation. According to numerous studies, expression and level changes of leptin are associated with the inflammatory and autoimmune diseases, including endometriosis and chronic endometritis. Hyperplastic and inflammatory diseases of the uterus are accompanied by a violation of the receptivity of the endometrium due to the dysregulation of many factors involved in proliferation, vascularization and decidualization of cells. Activity of most of these factors is due to the leptin action, however, there are no studies of the direct effect of leptin in the pathogenesis of disorders of the endometrium in hyperplastic and inflammatory diseases.Thus, the purpose of this literature review was to describe the putative molecular mechanisms of the effect of leptin on the development of endometrial pathology.Literature search was carried out from 03/20/2023 to 05/11/2023 using scientific literature databases: NCBI PubMed, Google Scholar (foreign sources), Cyberleninka, Elibrary (domestic sources): references for the period 1995-2023 were analyzed. The following keywords were used for the search: leptin, endometrial dysfunction, endometrial receptivity, inflammation, pelvic inflammatory disease.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"106-114"},"PeriodicalIF":0.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Combination of macro-TSH and macroprolactinemia phenomena in a patient with autoimmune thyroiditis and vitiligo]. [一名自身免疫性甲状腺炎和白癜风患者合并大TSH和巨泌乳素血症现象]。
Pub Date : 2024-11-05 DOI: 10.14341/probl13390
D V Sazonova, M A Perepelova, A S Shutova, L V Nikankina, G S Kolesnikova, E A Pigarova, L K Dzeranova

Laboratory diagnostic methods are the main tools in the practice of a doctor of any specialty, including an endocrinologist. Factors were identified that could change the concentration of the biologically active fraction of the test substance, subsequently complicating the interpretation of laboratory results and making the right clinical decision. The literature describes a variety of circulating autoantibodies involved in binding to pituitary hormones (prolactin (PRL), thyroid-stimulating hormone (TSH), growth hormone, luteinizing, follicle-stimulating, and adrenocorticotropic hormones), hypothalamus (vasopressin and oxytocin), pancreas (insulin and glucagon) , parathyroid glands (parathyroid hormone), as well as with thyroid hormones. As a rule, the resulting macromolecules lead to an increase in laboratory parameters, in which the prevailing fraction of the hormone does not have biological activity, which determines the main problem of this phenomenon. The most common variants include immune complexes with PRL and TSH, causing the phenomena of macroprolactinemia and macrothyrotropinemia (macro-TSH-emia/macro-TSH), respectively. Most laboratory test systems used in clinical practice are capable of determining only the total amount of PRL and TSH. The presented clinical observation describes a combination of the phenomena of macro-TSH and macroprolactinemia in a patient with autoimmune thyroiditis (AIT) and vitiligo.

实验室诊断方法是包括内分泌科医生在内的各科医生的主要实践工具。已确定的因素可能会改变检测物质生物活性部分的浓度,从而使实验室结果的解释和正确的临床决策变得复杂。文献描述了与垂体激素(催乳素(PRL)、促甲状腺激素(TSH)、生长激素、促黄体生成素、促卵泡激素和促肾上腺皮质激素)、下丘脑(血管加压素和催产素)、胰腺(胰岛素和胰高血糖素)、甲状旁腺(甲状旁腺激素)以及甲状腺激素结合的各种循环自身抗体。通常,由此产生的大分子会导致实验室参数的增加,其中大部分激素不具有生物活性,这就决定了这种现象的主要问题所在。最常见的变体包括 PRL 和 TSH 的免疫复合物,分别导致大泌乳素血症(macroprolactinemia)和大鱼鳞血症(macro-TSH-memia/macro-TSH)。临床上使用的大多数实验室检测系统只能测定 PRL 和 TSH 的总量。本临床观察报告描述了一名自身免疫性甲状腺炎(AIT)和白癜风患者同时患有巨TSH和巨泌乳素血症的情况。
{"title":"[Combination of macro-TSH and macroprolactinemia phenomena in a patient with autoimmune thyroiditis and vitiligo].","authors":"D V Sazonova, M A Perepelova, A S Shutova, L V Nikankina, G S Kolesnikova, E A Pigarova, L K Dzeranova","doi":"10.14341/probl13390","DOIUrl":"https://doi.org/10.14341/probl13390","url":null,"abstract":"<p><p>Laboratory diagnostic methods are the main tools in the practice of a doctor of any specialty, including an endocrinologist. Factors were identified that could change the concentration of the biologically active fraction of the test substance, subsequently complicating the interpretation of laboratory results and making the right clinical decision. The literature describes a variety of circulating autoantibodies involved in binding to pituitary hormones (prolactin (PRL), thyroid-stimulating hormone (TSH), growth hormone, luteinizing, follicle-stimulating, and adrenocorticotropic hormones), hypothalamus (vasopressin and oxytocin), pancreas (insulin and glucagon) , parathyroid glands (parathyroid hormone), as well as with thyroid hormones. As a rule, the resulting macromolecules lead to an increase in laboratory parameters, in which the prevailing fraction of the hormone does not have biological activity, which determines the main problem of this phenomenon. The most common variants include immune complexes with PRL and TSH, causing the phenomena of macroprolactinemia and macrothyrotropinemia (macro-TSH-emia/macro-TSH), respectively. Most laboratory test systems used in clinical practice are capable of determining only the total amount of PRL and TSH. The presented clinical observation describes a combination of the phenomena of macro-TSH and macroprolactinemia in a patient with autoimmune thyroiditis (AIT) and vitiligo.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"34-39"},"PeriodicalIF":0.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Insulin level, glycemia, insulin resistance and β-cell function in relation to the lifestyle of Arctic indigenous people. Are there conditions for diabetes and which type?] [胰岛素水平、血糖、胰岛素抵抗和β细胞功能与北极原住民的生活方式有关。是否有糖尿病的条件,是哪种类型?]
Pub Date : 2024-11-05 DOI: 10.14341/probl13411
A V Strelkova, F A Bichkaeva, O S Vlasova, E V Nesterova, B A Shengof, T B Gretskaya

Background: Modern studies suggest that lifestyle changes of the indigenous Arctic residents lead to the loss of the "adaptive polar type of metabolism", which is characterized by the intensification of protein metabolism, optimization of lipid metabolism, and minimization of carbohydrate metabolism at low insulin concentrations. How to survive the era of change?

Aim: To assess insulinemia, glycemia, β-cell secretory activity, and insulin sensitivity in Arctic indigenous people in relation to their lifestyle.

Materials and methods: A cross-sectional study of a population of indigenous Arctic residents (Nenets, Komi) aged from 22 to 60 years was conducted. Insulin levels were studied in blood serum using ELISA, and glucose levels using the spectrophotometric method. Insulin resistance (HOMA-IR) and β-cell function (HOMA1-%β) indices were calculated.

Results: 397 people were examined; 89 (22%) of them were nomadic people (NP) and 44 (49%) were male. Another 308 (78%) were sedentary people (SP), and 69 (22%) were male. The insulin level was significantly lower in NP (6.0 [3.5-11.8] µU/ml) compared to SP (8.3 [4.6-13.1] µU/ml), p=0.006. There was no difference in glycemia (4.6 [4.2-5.0] in NP and 4.6 [4.1-5.2] in SP) between lifestyles.The HOMA-IR was significantly lower in NP (1.3 [0.7-2.4]) than in SP (1.8 [0.95-2.8]), p=0.013. IR-HOMA >2 units was 1.8 times more frequent in the SP than in NP, with adjusted for sex, age, and BMI OR=0.56; 95% CI: 0.33-0.96, p=0.034. The median HOMA1-%β was 128 [67-241] % in NP and 144 [93-236]% in SP with no significant differences between groups. The proportion of individuals with HOMA1-%β <48.9 was 17% in NP versus 5% in SP, p<0.001. The adjusted odds of having HOMA1-%β <48.9 in NP are 3.5 times higher than in SP; 95% CI: 1.56-7.92, p=0.002. Fifty-six cases of glycemia ≥5.6 mmol/l were identified: 13.5% in NP and 14.3% in SP. The ratio IR-HOMA >2/ HOMA1-%β <48.9/BMI was 1.8 units/45%/25.2 kg/m2 in NP and 3.0 units/88%/29.6 kg/m2 in SP.

Conclusion: Maintaining a nomadic lifestyle helps keep lower insulin concentrations; at the same time, glycemic levels in the groups were similar. In the NP group, there was a high proportion of individuals with low β-cell secretory activity, predominantly men; in the SP group, more individuals were insulin-resistant. Analysis of cases of glycemia ≥5.6 mmol/l confirmed, that hyperglycemia in a nomadic lifestyle was associated with β-cell hypofunction and the absence of obesity; on the contrary, in a sedentary lifestyle, it was associated with increased insulin resistance and obesity.

背景:现代研究表明,北极土著居民生活方式的改变导致了 "适应性极地代谢 "的丧失,这种代谢的特点是在低胰岛素浓度下加强蛋白质代谢、优化脂质代谢和减少碳水化合物代谢。如何在变革时代生存下去?目的:评估北极原住民的胰岛素血症、血糖、β细胞分泌活性和胰岛素敏感性与其生活方式的关系:对 22 至 60 岁的北极原住居民(涅涅茨人、科米人)进行了横断面研究。使用酶联免疫吸附法研究了血清中的胰岛素水平,使用分光光度法研究了血糖水平。计算了胰岛素抵抗(HOMA-IR)和β细胞功能(HOMA1-%β)指数:受试者共 397 人,其中 89 人(22%)为游牧民族(NP),44 人(49%)为男性。另有 308 人(78%)为久坐人群(SP),其中 69 人(22%)为男性。游牧民的胰岛素水平(6.0 [3.5-11.8] µU/ml)明显低于定居者(8.3 [4.6-13.1] µU/ml),P=0.006。不同生活方式的血糖值(NP 为 4.6 [4.2-5.0] ,SP 为 4.6 [4.1-5.2])没有差异。NP 的 HOMA-IR 值(1.3 [0.7-2.4] )明显低于 SP(1.8 [0.95-2.8]),P=0.013。SP中IR-HOMA >2单位的发生率是NP的1.8倍,调整性别、年龄和体重指数后OR=0.56;95% CI:0.33-0.96,P=0.034。NP 和 SP 的 HOMA1-%β 中位数分别为 128 [67-241] % 和 144 [93-236]%,组间无显著差异。HOMA1-%β为48.9的患者比例在NP中为17%,在SP中为5%,P<0.001。NP 中 HOMA1-%β <48.9 的调整后几率是 SP 的 3.5 倍;95% CI:1.56-7.92,p=0.002。56 例血糖≥5.6 mmol/l:NP为13.5%,SP为14.3%。IR-HOMA>2/HOMA1-%β<48.9/BMI之比,NP为1.8单位/45%/25.2 kg/m2,SP为3.0单位/88%/29.6 kg/m2:保持游牧生活方式有助于保持较低的胰岛素浓度;同时,两组的血糖水平相似。在 NP 组中,β 细胞分泌活性低的人比例较高,主要是男性;在 SP 组中,胰岛素抵抗的人较多。对血糖≥5.6 毫摩尔/升病例的分析证实,游牧生活方式下的高血糖与 β 细胞功能低下和无肥胖有关;相反,久坐生活方式下的高血糖与胰岛素抵抗和肥胖增加有关。
{"title":"[Insulin level, glycemia, insulin resistance and β-cell function in relation to the lifestyle of Arctic indigenous people. Are there conditions for diabetes and which type?]","authors":"A V Strelkova, F A Bichkaeva, O S Vlasova, E V Nesterova, B A Shengof, T B Gretskaya","doi":"10.14341/probl13411","DOIUrl":"https://doi.org/10.14341/probl13411","url":null,"abstract":"<p><strong>Background: </strong>Modern studies suggest that lifestyle changes of the indigenous Arctic residents lead to the loss of the \"adaptive polar type of metabolism\", which is characterized by the intensification of protein metabolism, optimization of lipid metabolism, and minimization of carbohydrate metabolism at low insulin concentrations. How to survive the era of change?</p><p><strong>Aim: </strong>To assess insulinemia, glycemia, β-cell secretory activity, and insulin sensitivity in Arctic indigenous people in relation to their lifestyle.</p><p><strong>Materials and methods: </strong>A cross-sectional study of a population of indigenous Arctic residents (Nenets, Komi) aged from 22 to 60 years was conducted. Insulin levels were studied in blood serum using ELISA, and glucose levels using the spectrophotometric method. Insulin resistance (HOMA-IR) and β-cell function (HOMA1-%β) indices were calculated.</p><p><strong>Results: </strong>397 people were examined; 89 (22%) of them were nomadic people (NP) and 44 (49%) were male. Another 308 (78%) were sedentary people (SP), and 69 (22%) were male. The insulin level was significantly lower in NP (6.0 [3.5-11.8] µU/ml) compared to SP (8.3 [4.6-13.1] µU/ml), p=0.006. There was no difference in glycemia (4.6 [4.2-5.0] in NP and 4.6 [4.1-5.2] in SP) between lifestyles.The HOMA-IR was significantly lower in NP (1.3 [0.7-2.4]) than in SP (1.8 [0.95-2.8]), p=0.013. IR-HOMA &gt;2 units was 1.8 times more frequent in the SP than in NP, with adjusted for sex, age, and BMI OR=0.56; 95% CI: 0.33-0.96, p=0.034. The median HOMA1-%β was 128 [67-241] % in NP and 144 [93-236]% in SP with no significant differences between groups. The proportion of individuals with HOMA1-%β &lt;48.9 was 17% in NP versus 5% in SP, p&lt;0.001. The adjusted odds of having HOMA1-%β &lt;48.9 in NP are 3.5 times higher than in SP; 95% CI: 1.56-7.92, p=0.002. Fifty-six cases of glycemia ≥5.6 mmol/l were identified: 13.5% in NP and 14.3% in SP. The ratio IR-HOMA &gt;2/ HOMA1-%β &lt;48.9/BMI was 1.8 units/45%/25.2 kg/m2 in NP and 3.0 units/88%/29.6 kg/m2 in SP.</p><p><strong>Conclusion: </strong>Maintaining a nomadic lifestyle helps keep lower insulin concentrations; at the same time, glycemic levels in the groups were similar. In the NP group, there was a high proportion of individuals with low β-cell secretory activity, predominantly men; in the SP group, more individuals were insulin-resistant. Analysis of cases of glycemia ≥5.6 mmol/l confirmed, that hyperglycemia in a nomadic lifestyle was associated with β-cell hypofunction and the absence of obesity; on the contrary, in a sedentary lifestyle, it was associated with increased insulin resistance and obesity.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"54-69"},"PeriodicalIF":0.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficacy of standard methods in the treatment of prolactin-secreting pituitary carcinoma]. [标准方法治疗分泌催乳素垂体癌的疗效]。
Pub Date : 2024-11-05 DOI: 10.14341/probl13401
L I Astafyeva, P L Kalinin, Y Y Trunin, G L Kobyakov, Y G Sidneva

Pituitary carcinoma (metastatic neuroendocrine tumor of the pituitary gland) is the pituitary tumor with confirmed craniospinal and/or systemic metastases. These tumors are extremely rare accounting for only 0.1% to 0.5% of all pituitary tumours and are characterized by high mortality. In the presented case, pituitary carcinoma with intracranial metastasis was diagnosed in a young patient 25 years after manifestation of an aggressive recurrent prolactin-secreting pituitary tumor. Standard therapy (removal of metastasis, radiation therapy, cabergoline therapy) resulted in a long-term remission of the disease.

垂体癌(垂体转移性神经内分泌肿瘤)是指已证实有颅脑和/或全身转移的垂体肿瘤。这类肿瘤极为罕见,仅占所有垂体瘤的 0.1%至 0.5%,死亡率很高。在本病例中,一名年轻患者在出现侵袭性复发性分泌催乳素垂体瘤 25 年后被诊断为垂体癌伴颅内转移。标准治疗(转移灶切除、放射治疗、卡麦角林治疗)使病情长期缓解。
{"title":"[Efficacy of standard methods in the treatment of prolactin-secreting pituitary carcinoma].","authors":"L I Astafyeva, P L Kalinin, Y Y Trunin, G L Kobyakov, Y G Sidneva","doi":"10.14341/probl13401","DOIUrl":"https://doi.org/10.14341/probl13401","url":null,"abstract":"<p><p>Pituitary carcinoma (metastatic neuroendocrine tumor of the pituitary gland) is the pituitary tumor with confirmed craniospinal and/or systemic metastases. These tumors are extremely rare accounting for only 0.1% to 0.5% of all pituitary tumours and are characterized by high mortality. In the presented case, pituitary carcinoma with intracranial metastasis was diagnosed in a young patient 25 years after manifestation of an aggressive recurrent prolactin-secreting pituitary tumor. Standard therapy (removal of metastasis, radiation therapy, cabergoline therapy) resulted in a long-term remission of the disease.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"40-45"},"PeriodicalIF":0.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Meta-analysis of experimental studies of the effect of melatonin monotherapy on the levels of thyroid hormones and glucocorticoids in rats kept under standard condition]. [关于褪黑素单一疗法对标准条件下饲养的大鼠甲状腺激素和糖皮质激素水平影响的实验研究的元分析]。
Pub Date : 2024-11-05 DOI: 10.14341/probl13396
N V Kuzmenko, V A Tsyrlin, M G Pliss

Background: Melatonin is known to modulate circadian and seasonal rhythms in metabolism, reproduction, and behavior. However, the effect of exogenous melatonin supplementation on the functioning of the thyroid and adrenal glands in species without a clear seasonality in reproduction is still unclear.

Aim: Using a meta-analysis of publications, to investigate the effect of melatonin monotherapy on the concentrations of pituitary thyroid-stimulating hormone, thyroid hormones (TG), pituitary adrenocorticotropic hormone and corticosterone (CS) in rats kept under standard laboratory conditions.

Materials and methods: In our work, using the Review Manager 5.3 program, we conducted a meta-analysis of publications examining the effect of melatonin monotherapy on the functioning of the thyroid gland (22 papers) and adrenal glands (20 papers) in rats kept under standard conditions.

Results: According to the results of our meta-analysis, the effects of melatonin on the levels of TG and CS depend on the dose and duration of therapy. A decrease in TG and CS was associated with therapy lasting no more than 4-5 weeks and with high doses of melatonin. An increase in CS and a trend toward increased TG levels were observed with longer therapy. However, a few studies have observed a decrease in TG with very long-term melatonin therapy (≥32 weeks). Among all TGs, total thyroxine (T4) showed maximum sensitivity to exogenous melatonin, which indicates the influence of melatonin on the secretory function of the thyroid gland. In addition, melatonin increased the relative weight of the adrenal glands. There was no convincing evidence that the effects of melatonin were influenced by the route and timing of administration, or the timing of blood sampling.

Conclusion: As a result, exogenous melatonin can modulate TG and CS levels, even in species without a clear seasonality in reproductive function.

背景:众所周知,褪黑激素可调节新陈代谢、繁殖和行为的昼夜节律和季节性节律。目的:通过对出版物进行荟萃分析,研究褪黑激素单一疗法对标准实验室条件下饲养的大鼠垂体促甲状腺激素、甲状腺激素(TG)、垂体促肾上腺皮质激素和皮质酮(CS)浓度的影响:我们使用Review Manager 5.3程序对研究褪黑素单一疗法对标准条件下饲养大鼠甲状腺(22篇)和肾上腺(20篇)功能影响的文献进行了荟萃分析:根据我们的荟萃分析结果,褪黑素对TG和CS水平的影响取决于剂量和疗程。治疗时间不超过 4-5 周且褪黑素剂量较大时,TG 和 CS 会下降。治疗时间越长,CS 水平越高,TG 水平也呈上升趋势。不过,也有少数研究观察到,褪黑素治疗时间过长(≥32 周)会导致 TG 下降。在所有总胆固醇中,总甲状腺素(T4)对外源性褪黑激素的敏感性最高,这表明褪黑激素对甲状腺的分泌功能有影响。此外,褪黑激素还增加了肾上腺的相对重量。没有令人信服的证据表明褪黑激素的作用受给药途径、给药时间或采血时间的影响:因此,即使在生殖功能没有明显季节性的物种中,外源性褪黑激素也能调节TG和CS水平。
{"title":"[Meta-analysis of experimental studies of the effect of melatonin monotherapy on the levels of thyroid hormones and glucocorticoids in rats kept under standard condition].","authors":"N V Kuzmenko, V A Tsyrlin, M G Pliss","doi":"10.14341/probl13396","DOIUrl":"10.14341/probl13396","url":null,"abstract":"<p><strong>Background: </strong>Melatonin is known to modulate circadian and seasonal rhythms in metabolism, reproduction, and behavior. However, the effect of exogenous melatonin supplementation on the functioning of the thyroid and adrenal glands in species without a clear seasonality in reproduction is still unclear.</p><p><strong>Aim: </strong>Using a meta-analysis of publications, to investigate the effect of melatonin monotherapy on the concentrations of pituitary thyroid-stimulating hormone, thyroid hormones (TG), pituitary adrenocorticotropic hormone and corticosterone (CS) in rats kept under standard laboratory conditions.</p><p><strong>Materials and methods: </strong>In our work, using the Review Manager 5.3 program, we conducted a meta-analysis of publications examining the effect of melatonin monotherapy on the functioning of the thyroid gland (22 papers) and adrenal glands (20 papers) in rats kept under standard conditions.</p><p><strong>Results: </strong>According to the results of our meta-analysis, the effects of melatonin on the levels of TG and CS depend on the dose and duration of therapy. A decrease in TG and CS was associated with therapy lasting no more than 4-5 weeks and with high doses of melatonin. An increase in CS and a trend toward increased TG levels were observed with longer therapy. However, a few studies have observed a decrease in TG with very long-term melatonin therapy (≥32 weeks). Among all TGs, total thyroxine (T4) showed maximum sensitivity to exogenous melatonin, which indicates the influence of melatonin on the secretory function of the thyroid gland. In addition, melatonin increased the relative weight of the adrenal glands. There was no convincing evidence that the effects of melatonin were influenced by the route and timing of administration, or the timing of blood sampling.</p><p><strong>Conclusion: </strong>As a result, exogenous melatonin can modulate TG and CS levels, even in species without a clear seasonality in reproductive function.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"91-105"},"PeriodicalIF":0.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The use of TruCare III insulin pump in patients with type 1 diabetes mellitus]. [在 1 型糖尿病患者中使用 TruCare III 胰岛素泵]。
Pub Date : 2024-11-04 DOI: 10.14341/probl13516
I A Barsukov, A A Demina

The development of devices for continuous subcutaneous insulin infusion (CSII or insulin pumps) dramatically improved medical care for patients with diabetes mellitus. Insulin pump production widens annually resulting in number of new models entering the market, that differs in price but are similar in technical features. The entering of such new models to the Russian market can cause practical issues both in patient and in health care provider, so their estimation is of great importance. Insulin pump TruCare III (Apex Medical Co., Ltd, China) was registered in Russian Federation in September 15, 2023. The clinical experience of the TruCare III use in patients with type 1 diabetes mellitus is presented with the focus on glycemic parameters and custom features.

连续皮下胰岛素输注设备(CSII 或胰岛素泵)的开发极大地改善了糖尿病患者的医疗服务。胰岛素泵的生产每年都在扩大,导致许多价格不同但技术特点相似的新型号进入市场。这些新型号进入俄罗斯市场会给患者和医疗服务提供者带来实际问题,因此对其进行评估非常重要。胰岛素泵 TruCare III(中国 Apex 医疗有限公司)于 2023 年 9 月 15 日在俄罗斯联邦注册。本文介绍了 TruCare III 用于 1 型糖尿病患者的临床经验,重点是血糖参数和定制功能。
{"title":"[The use of TruCare III insulin pump in patients with type 1 diabetes mellitus].","authors":"I A Barsukov, A A Demina","doi":"10.14341/probl13516","DOIUrl":"https://doi.org/10.14341/probl13516","url":null,"abstract":"<p><p>The development of devices for continuous subcutaneous insulin infusion (CSII or insulin pumps) dramatically improved medical care for patients with diabetes mellitus. Insulin pump production widens annually resulting in number of new models entering the market, that differs in price but are similar in technical features. The entering of such new models to the Russian market can cause practical issues both in patient and in health care provider, so their estimation is of great importance. Insulin pump TruCare III (Apex Medical Co., Ltd, China) was registered in Russian Federation in September 15, 2023. The clinical experience of the TruCare III use in patients with type 1 diabetes mellitus is presented with the focus on glycemic parameters and custom features.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"70-75"},"PeriodicalIF":0.0,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cephalgic syndrome in patients with acromegaly]. [肢端肥大症患者头颅综合征]。
Pub Date : 2024-11-04 DOI: 10.14341/probl13423
G N Nurullina, I N Pushkarev, E G Przhiyalkovskaya

The aim of this review is to summarize the data available in the literature on the causes of headache in patients with acromegaly, as well as on the effect of various methods of acromegaly treatment on headache. Publications were searched in the PubMed database using the keywords «Headache in patients with acromegaly», «Headache in patients with pituitary adenomas», «Tension-type headache», «Migraine». Headache in patients with pituitary adenomas secreting somatotropic hormone (STH) is not uncommon: according to various authors, cephalgic syndrome occurs in 30-70% of patients with acromegaly and can worsen their quality of life, along with other factors, up to disability. By the nature of development, headache with acromegaly is classified into primary (migraine, tension headache, trigeminal autonomic cephalgia, for example, SUNCT syndrome and cluster headaches), and can also be caused by various causes directly related to the tumor. All this requires differential diagnosis. The factors causing headaches in somatotropinomas have not yet been well studied and require further research. These include the mass effect of the tumor, hormonal hypersecretion, pathology of the temporomandibular joint, sodium and fluid retention in the body, psychological factors, etc. The authors evaluated the effect on headache of various methods of acromegaly treatment: transnasal transsphenoidal adenomectomy, radiation therapy and drug therapy with somatostatin analogues, dopamine agonists and growth hormone receptor antagonist. However, even when normal levels of STH and insulin-like growth factor 1 (IGF-1) are reached, cephalgic syndrome may persist, therefore patients should be warned about this in advance and referred to a cephalgologist to select adequate headache therapy.

本综述旨在总结有关肢端肥大症患者头痛原因以及各种肢端肥大症治疗方法对头痛影响的现有文献数据。在PubMed数据库中以 "肢端肥大症患者的头痛"、"垂体腺瘤患者的头痛"、"紧张型头痛"、"偏头痛 "为关键词搜索相关文献。分泌促体液激素(STH)的垂体腺瘤患者出现头痛的情况并不少见:根据不同作者的研究,30%-70%的肢端肥大症患者会出现头痛综合征,该综合征会使患者的生活质量下降,并伴随其他因素,甚至致残。根据发病性质,肢端肥大症头痛可分为原发性头痛(偏头痛、紧张性头痛、三叉神经自主性头痛,如 SUNCT 综合征和丛集性头痛),也可由与肿瘤直接相关的各种原因引起。所有这些都需要进行鉴别诊断。导致躯体促性腺激素瘤患者头痛的因素尚未得到很好的研究,需要进一步研究。这些因素包括肿瘤的肿块效应、激素分泌过多、颞下颌关节病变、体内钠和液体潴留、心理因素等。作者评估了各种肢端肥大症治疗方法对头痛的影响:经鼻经蝶窦腺瘤切除术、放射治疗以及使用体生长激素类似物、多巴胺激动剂和生长激素受体拮抗剂的药物治疗。不过,即使 STH 和胰岛素样生长因子 1(IGF-1)达到正常水平,头痛综合征也可能持续存在,因此应事先提醒患者注意这一点,并将其转介给头痛专科医生,以选择适当的头痛治疗方法。
{"title":"[Cephalgic syndrome in patients with acromegaly].","authors":"G N Nurullina, I N Pushkarev, E G Przhiyalkovskaya","doi":"10.14341/probl13423","DOIUrl":"https://doi.org/10.14341/probl13423","url":null,"abstract":"<p><p>The aim of this review is to summarize the data available in the literature on the causes of headache in patients with acromegaly, as well as on the effect of various methods of acromegaly treatment on headache. Publications were searched in the PubMed database using the keywords «Headache in patients with acromegaly», «Headache in patients with pituitary adenomas», «Tension-type headache», «Migraine». Headache in patients with pituitary adenomas secreting somatotropic hormone (STH) is not uncommon: according to various authors, cephalgic syndrome occurs in 30-70% of patients with acromegaly and can worsen their quality of life, along with other factors, up to disability. By the nature of development, headache with acromegaly is classified into primary (migraine, tension headache, trigeminal autonomic cephalgia, for example, SUNCT syndrome and cluster headaches), and can also be caused by various causes directly related to the tumor. All this requires differential diagnosis. The factors causing headaches in somatotropinomas have not yet been well studied and require further research. These include the mass effect of the tumor, hormonal hypersecretion, pathology of the temporomandibular joint, sodium and fluid retention in the body, psychological factors, etc. The authors evaluated the effect on headache of various methods of acromegaly treatment: transnasal transsphenoidal adenomectomy, radiation therapy and drug therapy with somatostatin analogues, dopamine agonists and growth hormone receptor antagonist. However, even when normal levels of STH and insulin-like growth factor 1 (IGF-1) are reached, cephalgic syndrome may persist, therefore patients should be warned about this in advance and referred to a cephalgologist to select adequate headache therapy.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"14-22"},"PeriodicalIF":0.0,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Non-classical hormones from the fibroblast growth factor family]. [成纤维细胞生长因子家族的非典型激素]。
Pub Date : 2024-11-04 DOI: 10.14341/probl13441
S A Gronskaia, N V Rusyaeva, Zh E Belaya, G A Melnichenko

Fibroblast growth factors (FGFs) are a group of signaling molecules named for their ability to promote the growth and proliferation of fibroblasts and various other cell types. Typically, FGFs exert their effects locally by binding to receptors within the tissues where they are synthesized. However, certain members of this family, such as FGF 19, FGF 21, and FGF 23, diverge from this pattern. Following synthesis, these FGFs enter the bloodstream and act on distant organs and tissues by binding to their receptors and associated cofactors, thereby classified as non-classical hormones within the FGF family.The biological functions of FGFs are diverse and contingent upon the specific receptors and cofactors involved in their signaling pathways. For instance, FGF 19 and FGF 21 play crucial roles in regulating glucose and lipid metabolism, whereas FGF 23 primarily influences phosphorus metabolism. Given their varied roles, FGFs present promising targets for therapeutic interventions and drug development.This review aims to consolidate current understanding of FGF family hormones, elucidating their biological impacts and exploring their potential applications as therapeutic targets.

成纤维细胞生长因子(FGFs)是一组信号分子,因其能够促进成纤维细胞和其他各种细胞的生长和增殖而得名。通常情况下,成纤维细胞生长因子通过与其合成组织内的受体结合而在局部发挥作用。然而,该家族的某些成员,如 FGF 19、FGF 21 和 FGF 23,却与这种模式不同。合成后,这些 FGF 进入血液,通过与受体和相关辅助因子结合作用于远处的器官和组织,因此被归类为 FGF 家族中的非经典激素。FGF 的生物功能多种多样,取决于其信号传导途径中涉及的特定受体和辅助因子。例如,成纤维细胞生长因子 19 和成纤维细胞生长因子 21 在调节葡萄糖和脂质代谢方面发挥关键作用,而成纤维细胞生长因子 23 则主要影响磷代谢。本综述旨在巩固目前对 FGF 家族激素的认识,阐明其生物学影响,并探讨其作为治疗靶点的潜在应用。
{"title":"[Non-classical hormones from the fibroblast growth factor family].","authors":"S A Gronskaia, N V Rusyaeva, Zh E Belaya, G A Melnichenko","doi":"10.14341/probl13441","DOIUrl":"https://doi.org/10.14341/probl13441","url":null,"abstract":"<p><p>Fibroblast growth factors (FGFs) are a group of signaling molecules named for their ability to promote the growth and proliferation of fibroblasts and various other cell types. Typically, FGFs exert their effects locally by binding to receptors within the tissues where they are synthesized. However, certain members of this family, such as FGF 19, FGF 21, and FGF 23, diverge from this pattern. Following synthesis, these FGFs enter the bloodstream and act on distant organs and tissues by binding to their receptors and associated cofactors, thereby classified as non-classical hormones within the FGF family.The biological functions of FGFs are diverse and contingent upon the specific receptors and cofactors involved in their signaling pathways. For instance, FGF 19 and FGF 21 play crucial roles in regulating glucose and lipid metabolism, whereas FGF 23 primarily influences phosphorus metabolism. Given their varied roles, FGFs present promising targets for therapeutic interventions and drug development.This review aims to consolidate current understanding of FGF family hormones, elucidating their biological impacts and exploring their potential applications as therapeutic targets.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"23-33"},"PeriodicalIF":0.0,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of the provision of medical care using telemedicine technologies at the endocrinology research centre]. [分析内分泌学研究中心利用远程医疗技术提供的医疗服务]。
Pub Date : 2024-11-04 DOI: 10.14341/probl13500
A S Nazarova, S S Prikazchikova, V Y Kalashnikov, G A Melnichenko, N G Mokrysheva

Background: In the first months after the pandemic of the COVID-19, the provision of medical care through telemedicine technologies took a leading position, in particular regarding endocrine nosologies. Meanwhile, at present, comprehensive information on telecommunications interaction between doctors of various medical organizations of the regions of the Russian Federation and employees of federal centers is insufficient, which determines the relevance of studying this topic.

Aim: Analysis of the provision of medical care in remote interaction of medical workers using telemedicine technologies («doctor-doctor») between the Endocrinology Research Centre and the regions of the Russian Federation in 2019-2023.

Materials and methods: A single-center, observational, single-sample study was conducted, including completed planned and urgent telemedicine consultations in the format of «doctor-doctor « in the fields of «endocrinology» and «pedia-tric endocrinology», conducted through a telemedicine system for remote consultations at federal and regional levels between 2019 and 2023. Data on the referral rate of medical personnel from the regions of the Russian Federation to the Endocrinology Research Centre for telemedicine consultations were analyzed, including annual dynamics of treatment, frequency of referrals from each region, nosological structure of referrals, and number of patients admitted to the center based on the results of these consultations. Analysis of interdepartmental cooperation between the Endocrinology Research Centre and other federal centers was also performed.

Results: In the period from 2019-2023, 14,475 telemedicine consultations «doctor-doctor» were conducted. In 2019, medical workers from 78 regions of the Russian Federation applied to the Endocrinology Research Centre. By 2023, this figure has increased to 88 (including newly annexed territories). The Yamalo-Nenets Autonomous Okrug, Tambov Region and Astrakhan Region were the leading regions in terms of the circulation of medicines at the Endocrinology Research Centre. In the nosological structure, the largest number of consultations in adult patients were conducted for acromegaly and primary hyperparathyroidism, in children for stunting and type 1 diabetes mellitus. In the period from 2019-2023, the Endocrinology Research Centre sent a total of 300 «outgoing» requests to 17 medical organizations.

Conclusion: Consulting with the use of telemedicine technologies has become a convenient and multifunctional way of providing medical care. Further analysis of the place of telemedicine in practical healthcare will expand its capabilities, including considering the introduction of financing by the territorial fund of compulsory medical insurance for this area of medical activity.

背景:在 COVID-19 大流行后的头几个月,通过远程医疗技术提供医疗服务占据了主导地位,尤其是在内分泌疾病方面。同时,目前关于俄罗斯联邦各地区医疗机构医生与联邦中心员工之间电信互动的综合信息不足,这决定了研究该课题的相关性。目的:分析 2019-2023 年内分泌学研究中心与俄罗斯联邦各地区之间医务工作者利用远程医疗技术("医生-医生")远程互动提供医疗服务的情况:进行了一项单中心、观察性、单样本研究,包括2019年至2023年期间通过联邦和地区远程会诊系统在 "内分泌学 "和 "儿科内分泌学 "领域以 "医生-医生 "形式完成的计划性和紧急远程会诊。对俄罗斯联邦各地区医务人员转诊到内分泌学研究中心进行远程会诊的数据进行了分析,包括年度治疗动态、各地区转诊频率、转诊病种结构以及根据这些会诊结果被中心收治的患者人数。此外,还对内分泌学研究中心与其他联邦中心之间的部门间合作进行了分析:在2019-2023年期间,共进行了14475次 "医生-医生 "远程医疗会诊。2019 年,来自俄罗斯联邦 78 个地区的医务工作者向内分泌学研究中心提出了申请。到 2023 年,这一数字增至 88 个(包括新吞并的领土)。亚马尔-涅涅茨自治区、坦波夫州和阿斯特拉罕州是内分泌学研究中心药品流通量最大的地区。在病种结构方面,成人患者中就诊人数最多的病种是肢端肥大症和原发性甲状旁腺功能亢进症,儿童患者中就诊人数最多的病种是发育迟缓和1型糖尿病。2019-2023年期间,内分泌学研究中心共向17家医疗机构发出了300份 "外出 "请求:利用远程医疗技术进行咨询已成为一种便捷、多功能的医疗服务方式。对远程医疗在实际医疗保健中的地位的进一步分析将扩大其能力,包括考虑由强制性医疗保险地区基金为这一医疗活动领域提供资金。
{"title":"[Analysis of the provision of medical care using telemedicine technologies at the endocrinology research centre].","authors":"A S Nazarova, S S Prikazchikova, V Y Kalashnikov, G A Melnichenko, N G Mokrysheva","doi":"10.14341/probl13500","DOIUrl":"10.14341/probl13500","url":null,"abstract":"<p><strong>Background: </strong>In the first months after the pandemic of the COVID-19, the provision of medical care through telemedicine technologies took a leading position, in particular regarding endocrine nosologies. Meanwhile, at present, comprehensive information on telecommunications interaction between doctors of various medical organizations of the regions of the Russian Federation and employees of federal centers is insufficient, which determines the relevance of studying this topic.</p><p><strong>Aim: </strong>Analysis of the provision of medical care in remote interaction of medical workers using telemedicine technologies («doctor-doctor») between the Endocrinology Research Centre and the regions of the Russian Federation in 2019-2023.</p><p><strong>Materials and methods: </strong>A single-center, observational, single-sample study was conducted, including completed planned and urgent telemedicine consultations in the format of «doctor-doctor « in the fields of «endocrinology» and «pedia-tric endocrinology», conducted through a telemedicine system for remote consultations at federal and regional levels between 2019 and 2023. Data on the referral rate of medical personnel from the regions of the Russian Federation to the Endocrinology Research Centre for telemedicine consultations were analyzed, including annual dynamics of treatment, frequency of referrals from each region, nosological structure of referrals, and number of patients admitted to the center based on the results of these consultations. Analysis of interdepartmental cooperation between the Endocrinology Research Centre and other federal centers was also performed.</p><p><strong>Results: </strong>In the period from 2019-2023, 14,475 telemedicine consultations «doctor-doctor» were conducted. In 2019, medical workers from 78 regions of the Russian Federation applied to the Endocrinology Research Centre. By 2023, this figure has increased to 88 (including newly annexed territories). The Yamalo-Nenets Autonomous Okrug, Tambov Region and Astrakhan Region were the leading regions in terms of the circulation of medicines at the Endocrinology Research Centre. In the nosological structure, the largest number of consultations in adult patients were conducted for acromegaly and primary hyperparathyroidism, in children for stunting and type 1 diabetes mellitus. In the period from 2019-2023, the Endocrinology Research Centre sent a total of 300 «outgoing» requests to 17 medical organizations.</p><p><strong>Conclusion: </strong>Consulting with the use of telemedicine technologies has become a convenient and multifunctional way of providing medical care. Further analysis of the place of telemedicine in practical healthcare will expand its capabilities, including considering the introduction of financing by the territorial fund of compulsory medical insurance for this area of medical activity.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"4-13"},"PeriodicalIF":0.0,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Problemy endokrinologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1